Arresto BioSciences' Acquisition

Arresto BioSciences was acquired by Gilead Sciences on December 10, 2010.

Arresto Biosciences is a biotech company that develops medicines to treat cancer and fibrotic diseases by targeting extracellular matrix proteins. Changes in the normal composition of the extracellula…

Articles about Arresto BioSciences' Acquisition: